1. Home
  2. SPRO vs SMJF Comparison

SPRO vs SMJF Comparison

Compare SPRO & SMJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.24

Market Cap

124.5M

Sector

Health Care

ML Signal

HOLD

SMJF

SMJ International Holdings Inc. Class A Ordinary Shares

N/A

Current Price

$3.12

Market Cap

123.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SPRO
SMJF
Founded
2013
1988
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.5M
123.8M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SPRO
SMJF
Price
$2.24
$3.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
261.3K
190.4K
Earning Date
03-26-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
111.81
N/A
EPS
0.15
N/A
Revenue
$66,802,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.53
$68.08
Revenue Growth
39.24
N/A
52 Week Low
$0.51
$0.82
52 Week High
$3.09
$5.70

Technical Indicators

Market Signals
Indicator
SPRO
SMJF
Relative Strength Index (RSI) 39.83 48.99
Support Level $2.15 $0.82
Resistance Level $2.44 $3.78
Average True Range (ATR) 0.13 0.34
MACD -0.02 0.07
Stochastic Oscillator 4.35 67.65

Price Performance

Historical Comparison
SPRO
SMJF

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About SMJF SMJ International Holdings Inc. Class A Ordinary Shares

SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, broadloom carpets and vinyl tiles. The company operates under the proprietary brand 'SMJ'.The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. It has presence in several countries including Malaysia, Indonesia, Philippines, Hong Kong, PRC, Taiwan, Korea, Thailand, Vietnam, Brunei, and India. It generates revenue mainly through the sale and distribution of its flooring products prominently in Singapore.

Share on Social Networks: